Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
29 studies found for:    United States, Indiana | Community Regional Cancer Care
Show Display Options
Download search resultsDownload the search results for:
United States, Indiana | Community Regional Cancer Care (29 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
2 Recruiting Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Biological: cetuximab;   Radiation: intensity-modulated radiation therapy
3 Unknown  Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer
Conditions: Depression;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: management of therapy complications;   Procedure: pain therapy;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
4 Active, not recruiting Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Conditions: Head and Neck Cancer;   Precancerous Condition
Interventions: Biological: cetuximab;   Drug: cisplatin
5 Active, not recruiting
Has Results
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation;   Radiation: Radiation Therapy
6 Recruiting Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors;   Neurotoxicity
Interventions: Drug: temozolomide;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
7 Active, not recruiting Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
Conditions: Cognitive/Functional Effects;   Metastatic Cancer;   Neurotoxicity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: memantine hydrochloride;   Other: placebo;   Radiation: radiation therapy
8 Active, not recruiting High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Lung Cancer;   Radiation Toxicity
Interventions: Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel;   Radiation: 3-dimensional conformal radiation therapy
9 Active, not recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Other: Placebo
10 Suspended Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Pembrolizumab
11 Completed Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
Condition: Carcinoma of Unknown Primary
Intervention: Radiation: radiation therapy
12 Withdrawn Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Conditions: Stage III Adult Soft Tissue Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Stage IVA Adult Soft Tissue Sarcoma;   Stage IIB Adult Soft Tissue Sarcoma;   Stage IIC Adult Soft Tissue Sarcoma
Interventions: Drug: doxorubicin;   Drug: filgrastim;   Drug: ifosfamide;   Procedure: biological response modifier therapy;   Procedure: brachytherapy;   Procedure: chemotherapy;   Procedure: colony-stimulating factor therapy;   Procedure: conventional surgery;   Procedure: cytokine therapy;   Procedure: intraoperative radiotherapy;   Procedure: radiation therapy;   Procedure: surgery
13 Completed Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
Condition: Lung Cancer
Interventions: Biological: monoclonal antibody 11D10 anti-idiotype vaccine;   Biological: monoclonal antibody 3H1 anti-idiotype vaccine;   Radiation: radiation therapy
14 Active, not recruiting Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: flutamide;   Drug: releasing hormone agonist therapy;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
15 Completed Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
Conditions: Anemia;   Head and Neck Cancer
Interventions: Biological: epoetin alfa;   Drug: cisplatin;   Radiation: radiation therapy
16 Completed S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Procedure: conventional surgery
17 Completed Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Radiation: radiation therapy
18 Completed Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
Conditions: Breast Cancer;   Perioperative/Postoperative Complications
Interventions: Behavioral: patient interviewing to obtain menstrual history;   Procedure: blood sampling
19 Active, not recruiting Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
Condition: Head and Neck Cancer
Intervention: Radiation: radiation therapy
20 Recruiting NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
Conditions: Advanced Malignant Neoplasm;   Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm
Interventions: Drug: Afatinib;   Drug: Akt inhibitor AZD5363;   Drug: Binimetinib;   Drug: Crizotinib;   Other: Cytology Specimen Collection Procedure;   Drug: Dabrafenib;   Drug: Dasatinib;   Drug: Defactinib;   Drug: FGFR Inhibitor AZD4547;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Drug: Osimertinib;   Drug: Palbociclib;   Drug: PI3K-beta Inhibitor GSK2636771;   Drug: Sunitinib Malate;   Drug: Taselisib;   Drug: Trametinib;   Biological: Trastuzumab Emtansine;   Drug: Vismodegib

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.